> top > docs > PMC:3586680 > spans > 0-289 > annotations

PMC:3586680 / 0-289 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T41 17-21 Protein denotes WWOX
T42 26-29 Protein denotes p53
T59 17-21 Protein denotes WWOX
T60 26-29 Protein denotes p53
T62 252-287 Protein denotes WW domain-containing oxidoreductase
T61 106-109 Protein denotes p53
T44 252-287 Protein denotes WW domain-containing oxidoreductase
T43 106-109 Protein denotes p53

testone

Id Subject Object Predicate Lexical cue
T19 17-21 Protein denotes WWOX
T20 26-29 Protein denotes p53
T22 252-287 Protein denotes WW domain-containing oxidoreductase
T21 106-109 Protein denotes p53

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T474 6-21 Protein denotes Suppressor WWOX
T475 26-29 Protein denotes p53
T476 106-109 Protein denotes p53

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T552 0-5 NNP denotes Tumor
T553 6-16 NNP denotes Suppressor
T554 17-21 NNP denotes WWOX
T555 22-25 CC denotes and
T556 26-29 NN denotes p53
T557 30-41 NNS denotes Alterations
T558 42-45 CC denotes and
T559 46-50 NN denotes Drug
T560 51-61 NN denotes Resistance
T561 62-64 IN denotes in
T562 65-78 NNP denotes Glioblastomas
T595 273-287 NN denotes oxidoreductase
T594 255-272 JJ denotes domain-containing
T593 252-254 NNP denotes WW
T592 250-251 . denotes .
T591 245-250 NNS denotes drugs
T590 233-244 JJ denotes therapeutic
T589 229-232 CC denotes and
T588 227-228 -RRB- denotes )
T587 224-227 NNP denotes TMZ
T586 223-224 -LRB- denotes (
T585 210-222 VB denotes temozolomide
T584 207-209 TO denotes to
T583 196-206 NN denotes resistance
T582 193-195 TO denotes to
T581 191-192 , denotes ,
T580 187-191 NN denotes part
T579 184-186 IN denotes in
T578 182-183 , denotes ,
T577 172-182 VB denotes contribute
T576 169-171 TO denotes to
T575 161-168 VBZ denotes appears
T574 157-160 CC denotes and
T573 155-156 -RRB- denotes )
T572 151-155 NNS denotes GBMs
T571 150-151 -LRB- denotes (
T570 136-149 NNS denotes glioblastomas
T569 133-135 IN denotes in
T568 125-132 VBN denotes mutated
T567 114-124 RB denotes frequently
T566 110-113 VBP denotes are
T565 106-109 NN denotes p53
T564 95-105 NN denotes suppressor
T563 89-94 NNP denotes Tumor
R265 T552 T554 compound Tumor,WWOX
R266 T553 T554 compound Suppressor,WWOX
R267 T554 T568 nsubjpass WWOX,mutated
R268 T555 T554 cc and,WWOX
R269 T556 T557 compound p53,Alterations
R270 T557 T554 conj Alterations,WWOX
R271 T558 T557 cc and,Alterations
R272 T559 T560 compound Drug,Resistance
R273 T560 T557 conj Resistance,Alterations
R274 T561 T557 prep in,Alterations
R275 T562 T565 compound Glioblastomas,p53
R276 T563 T565 compound Tumor,p53
R277 T564 T565 compound suppressor,p53
R278 T565 T561 pobj p53,in
R279 T566 T568 auxpass are,mutated
R280 T567 T568 advmod frequently,mutated
R281 T568 T568 ROOT mutated,mutated
R282 T569 T568 prep in,mutated
R283 T570 T569 pobj glioblastomas,in
R284 T571 T572 punct (,GBMs
R285 T572 T570 appos GBMs,glioblastomas
R286 T573 T568 punct ),mutated
R287 T574 T568 cc and,mutated
R288 T575 T568 conj appears,mutated
R289 T576 T577 aux to,contribute
R290 T577 T575 xcomp contribute,appears
R291 T578 T577 punct ",",contribute
R292 T579 T575 prep in,appears
R293 T580 T579 pobj part,in
R294 T581 T575 punct ",",appears
R295 T582 T583 aux to,resistance
R296 T583 T568 advcl resistance,mutated
R297 T584 T585 aux to,temozolomide
R298 T585 T583 advcl temozolomide,resistance
R299 T586 T587 punct (,TMZ
R300 T587 T585 appos TMZ,temozolomide
R301 T588 T587 punct ),TMZ
R302 T589 T585 cc and,temozolomide
R303 T590 T591 amod therapeutic,drugs
R304 T591 T585 conj drugs,temozolomide
R305 T592 T568 punct .,mutated

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T529 17-21 Protein denotes WWOX
T546 26-29 Protein denotes p53
T537 252-287 Protein denotes WW domain-containing oxidoreductase
T535 210-228 Entity denotes temozolomide (TMZ)
T526 233-250 Entity denotes therapeutic drugs
T525 89-109 Protein denotes Tumor suppressor p53
T523 224-227 Entity denotes TMZ

DLUT931

Id Subject Object Predicate Lexical cue
T397 17-21 Protein denotes WWOX
T398 26-29 Protein denotes p53
T415 30-41 Regulation denotes Alterations
T400 252-287 Protein denotes WW domain-containing oxidoreductase
T399 106-109 Protein denotes p53
R212 T397 T415 themeOf WWOX,Alterations
R213 T398 T415 themeOf p53,Alterations

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T447 17-21 Protein denotes WWOX
T448 26-29 Protein denotes p53
T465 30-41 Regulation denotes Alterations
T450 252-287 Protein denotes WW domain-containing oxidoreductase
T449 106-109 Protein denotes p53
R230 T448 T465 themeOf p53,Alterations

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T355 17-21 Protein denotes WWOX
T356 26-29 Protein denotes p53
T358 252-287 Protein denotes WW domain-containing oxidoreductase
T357 106-109 Protein denotes p53

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T390 26-29 http://www.uniprot.org/uniprot/P04637 denotes p53
T396 89-109 http://www.uniprot.org/uniprot/P04637 denotes Tumor suppressor p53
T391 106-109 http://www.uniprot.org/uniprot/P04637 denotes p53
T381 17-21 http://www.uniprot.org/uniprot/Q9NZC7 denotes WWOX

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T118 17-21 Protein denotes WWOX
T119 26-29 Protein denotes p53
T120 106-109 Protein denotes p53
T121 252-287 Protein denotes WW domain-containing oxidoreductase

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T166 0-5 NN denotes Tumor
T167 6-16 NN denotes Suppressor
T168 17-21 NN denotes WWOX
T169 22-25 CC denotes and
T170 26-29 NN denotes p53
T171 30-41 NN denotes Alterations
T172 42-45 CC denotes and
T173 46-50 NNP denotes Drug
T174 51-61 NNP denotes Resistance
T175 62-64 IN denotes in
T176 65-78 NN denotes Glioblastomas
T208 273-287 NN denotes oxidoreductase
T207 255-272 JJ denotes domain-containing
T206 252-254 JJ denotes WW
T205 245-250 NN denotes drugs
T204 233-244 JJ denotes therapeutic
T203 229-232 CC denotes and
T202 227-228 -RRB- denotes )
T201 224-227 NN denotes TMZ
T200 223-224 -LRB- denotes (
T199 210-222 NN denotes temozolomide
T198 207-209 TO denotes to
T197 196-206 NN denotes resistance
T196 193-195 TO denotes to
T195 191-192 -COMMA- denotes ,
T194 187-191 NN denotes part
T193 184-186 IN denotes in
T192 182-183 -COMMA- denotes ,
T191 172-182 VB denotes contribute
T190 169-171 TO denotes to
T189 161-168 VB denotes appears
T188 157-160 CC denotes and
T187 155-156 -RRB- denotes )
T186 151-155 NN denotes GBMs
T185 150-151 -LRB- denotes (
T184 136-149 NN denotes glioblastomas
T183 133-135 IN denotes in
T182 125-132 VB denotes mutated
T181 114-124 RB denotes frequently
T180 110-113 VB denotes are
T179 106-109 NN denotes p53
T178 95-105 NN denotes suppressor
T177 89-94 NN denotes Tumor
R28 T168 T166 arg1Of WWOX,Tumor
R29 T168 T167 arg1Of WWOX,Suppressor
R30 T168 T169 arg1Of WWOX,and
R31 T169 T175 arg1Of and,in
R32 T171 T170 arg1Of Alterations,p53
R33 T171 T172 arg1Of Alterations,and
R34 T172 T169 arg2Of and,and
R35 T174 T172 arg2Of Resistance,and
R36 T174 T173 arg1Of Resistance,Drug
R37 T176 T175 arg2Of Glioblastomas,in
R38 T179 T177 arg1Of p53,Tumor
R39 T179 T178 arg1Of p53,suppressor
R40 T179 T180 arg1Of p53,are
R41 T179 T182 arg2Of p53,mutated
R42 T179 T189 arg1Of p53,appears
R43 T179 T191 arg1Of p53,contribute
R44 T182 T180 arg2Of mutated,are
R45 T182 T181 arg1Of mutated,frequently
R46 T182 T183 arg1Of mutated,in
R47 T182 T188 arg1Of mutated,and
R48 T184 T183 arg2Of glioblastomas,in
R49 T184 T185 arg1Of glioblastomas,(
R50 T186 T185 arg2Of GBMs,(
R51 T187 T185 arg3Of ),(
R52 T189 T188 arg2Of appears,and
R53 T191 T189 arg2Of contribute,appears
R54 T191 T190 arg1Of contribute,to
R55 T191 T192 arg1Of contribute,","
R56 T191 T193 arg1Of contribute,in
R57 T191 T195 arg1Of contribute,","
R58 T191 T196 arg1Of contribute,to
R59 T194 T193 arg2Of part,in
R60 T197 T198 arg1Of resistance,to
R61 T197 T203 arg1Of resistance,and
R62 T199 T198 arg2Of temozolomide,to
R63 T199 T200 arg1Of temozolomide,(
R64 T201 T200 arg2Of TMZ,(
R65 T202 T200 arg3Of ),(
R66 T203 T196 arg2Of and,to
R67 T205 T203 arg2Of drugs,and
R68 T205 T204 arg1Of drugs,therapeutic

GO-BP

Id Subject Object Predicate Lexical cue
T136 0-16 http://purl.obolibrary.org/obo/GO_0051726 denotes Tumor Suppressor
T139 46-61 http://purl.obolibrary.org/obo/GO_0042493 denotes Drug Resistance
T137 89-105 http://purl.obolibrary.org/obo/GO_0051726 denotes Tumor suppressor

sentences

Id Subject Object Predicate Lexical cue
T79 0-78 Sentence denotes Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
T80 89-251 Sentence denotes Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs.
T1 0-78 Sentence denotes Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
T2 80-88 Sentence denotes Abstract
T3 89-251 Sentence denotes Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs.

simple1

Id Subject Object Predicate Lexical cue
T148 17-21 Protein denotes WWOX
T149 26-29 Protein denotes p53
T151 252-287 Protein denotes WW domain-containing oxidoreductase
T150 106-109 Protein denotes p53